Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Piddock

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1996
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animalsD J Griggs, K Gensberg, L J Piddock
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosisL J Piddock, K J Williams, V Ricci
The Journal of Antimicrobial Chemotherapy|May 1, 1996
gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong KongK J Williams, R Chan, L J Piddock
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteinsL J Piddock, E A Traynor, R Wise
The Journal of Antimicrobial Chemotherapy|December 1, 1989
The effect of mutations in the SOS response on the kinetics of quinolone killingR N Walters, L J Piddock, R Wise
Antimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of CGP 31608, a new penemR Wise, J M Andrews, L J Piddock
The Journal of Antimicrobial Chemotherapy|March 1, 1990
The accumulation of five quinolone antibacterial agents by Escherichia coliJ M Diver, L J Piddock, R Wise
The Journal of Antimicrobial Chemotherapy|December 1, 1990
A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant EnterobacteriaceaeL J Piddock, E A Traynor, R Wise
Antimicrobial Agents and Chemotherapy|June 1, 1990
Mechanism of action of lomefloxacinL J Piddock, M C Hall, R Wise
The Journal of Antimicrobial Chemotherapy|February 1, 1985
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsR Wise, J M Andrews, L J Piddock
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|April 1, 1996
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animalsD J Griggs, K Gensberg, L J Piddock
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosisL J Piddock, K J Williams, V Ricci
The Journal of Antimicrobial Chemotherapy|May 1, 1996
gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong KongK J Williams, R Chan, L J Piddock
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteinsL J Piddock, E A Traynor, R Wise
The Journal of Antimicrobial Chemotherapy|December 1, 1989
The effect of mutations in the SOS response on the kinetics of quinolone killingR N Walters, L J Piddock, R Wise
Antimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of CGP 31608, a new penemR Wise, J M Andrews, L J Piddock
The Journal of Antimicrobial Chemotherapy|March 1, 1990
The accumulation of five quinolone antibacterial agents by Escherichia coliJ M Diver, L J Piddock, R Wise
The Journal of Antimicrobial Chemotherapy|December 1, 1990
A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant EnterobacteriaceaeL J Piddock, E A Traynor, R Wise
Antimicrobial Agents and Chemotherapy|June 1, 1990
Mechanism of action of lomefloxacinL J Piddock, M C Hall, R Wise
The Journal of Antimicrobial Chemotherapy|February 1, 1985
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsR Wise, J M Andrews, L J Piddock
Pageof 10